Adaptive Biotechnologies Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.37 | -$0.32 | -$0.35 |
| Q2 2024 | 3 | -$0.35 | -$0.31 | -$0.33 |
| Q3 2024 | 1 | -$0.30 | -$0.27 | -$0.29 |
| Q4 2024 | 4 | -$0.27 | -$0.23 | -$0.26 |
| Q1 2025 | 4 | -$0.31 | -$0.25 | -$0.28 |
| Q2 2025 | 2 | -$0.25 | -$0.22 | -$0.24 |
| Q3 2025 | 2 | -$0.23 | -$0.21 | -$0.22 |
| Q4 2025 | 2 | -$0.22 | -$0.20 | -$0.21 |
| Q1 2026 | 1 | -$0.25 | -$0.22 | -$0.24 |
| Q2 2026 | 1 | -$0.19 | -$0.16 | -$0.18 |
| Q3 2026 | 1 | -$0.15 | -$0.13 | -$0.15 |
| Q4 2026 | 1 | -$0.15 | -$0.13 | -$0.14 |
Adaptive Biotechnologies Corporation Earnings Date And Information
Adaptive Biotechnologies Corporation last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.22 earnings per share for the quarter, topping analysts' consensus estimates of $-0.29 by $0.07. The company had revenue of 46.44 M for the quarter and had revenue of 170.28 M for the year. Adaptive Biotechnologies Corporation has generated $-2 earnings per share over the last year ($-1.56 diluted earnings per share) and currently has a price-to-earnings ratio of -3.54. Adaptive Biotechnologies Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 12th, 2025 based on prior year's report dates.
Adaptive Biotechnologies Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.29 | -$0.22 | 0.07 | $40.24 M | $46.44 M |
| 08/01/2024 | Q2 2024 | -$0.32 | -$0.31 | 0.01 | $38.63 M | $43.19 M |
| 05/07/2024 | Q1 2024 | -$0.35 | -$0.33 | 0.02 | $41.87 M | |
| 02/29/2024 | Q4 2023 | -$0.48 | $45.78 M | |||
| 11/09/2023 | Q3 2023 | -$0.32 | -$0.35 | -0.03 | $42.96 M | $37.92 M |
| 08/02/2023 | Q2 2023 | -$0.33 | -$0.33 | 0 | $44.87 M | $48.93 M |
| 05/03/2023 | Q1 2023 | -$0.34 | -$0.43 | -0.09 | $37.65 M | |
| 02/14/2023 | Q4 2022 | -$0.37 | -$0.17 | 0.2 | $55.20 M | |
| 11/03/2022 | Q3 2022 | -$0.37 | -$0.32 | 0.05 | $47.81 M | $47.83 M |
| 08/03/2022 | Q2 2022 | -$0.40 | -$0.37 | 0.03 | $41.81 M | $43.66 M |
| 05/04/2022 | Q1 2022 | -$0.43 | -$0.44 | -0.01 | $38.62 M | |
| 02/15/2022 | Q4 2021 | -$0.43 | -$0.44 | -0.01 | $37.93 M | |
| 11/03/2021 | Q3 2021 | -$0.43 | -$0.40 | 0.03 | $36.63 M | $39.47 M |
| 08/04/2021 | Q2 2021 | -$0.43 | -$0.35 | 0.08 | $31.27 M | $38.51 M |
| 05/05/2021 | Q1 2021 | -$0.41 | -$0.29 | 0.12 | $38.44 M | |
| 02/24/2021 | Q4 2020 | -$0.30 | -$0.33 | -0.03 | $30.19 M | |
| 11/10/2020 | Q3 2020 | -$0.28 | -$0.27 | 0.01 | $23.59 M | $26.30 M |
| 08/10/2020 | Q2 2020 | -$0.30 | -$0.26 | 0.04 | $18.80 M | $20.99 M |
| 05/12/2020 | Q1 2020 | -$0.22 | -$0.25 | -0.03 | $20.91 M | |
| 02/26/2020 | Q4 2019 | -$0.16 | -$0.17 | -0.01 | $24.21 M |
Adaptive Biotechnologies Corporation Earnings: Frequently Asked Questions
-
When is Adaptive Biotechnologies Corporation's earnings date?
Adaptive Biotechnologies Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 12th, 2025 based off last year's report dates.
-
Did Adaptive Biotechnologies Corporation beat their earnings estimates last quarter?
In the previous quarter, Adaptive Biotechnologies Corporation (:ADPT) reported $-0.22 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.29 by $0.07.
-
How can I listen to Adaptive Biotechnologies Corporation's earnings conference call?
The conference call for Adaptive Biotechnologies Corporation's latest earnings report can be listened to online.
-
How can I read Adaptive Biotechnologies Corporation's conference call transcript?
The conference call transcript for Adaptive Biotechnologies Corporation's latest earnings report can be read online.
-
How much revenue does Adaptive Biotechnologies Corporation generate each year?
Adaptive Biotechnologies Corporation (:ADPT) has a recorded annual revenue of $170.28 M.
-
How much profit does Adaptive Biotechnologies Corporation generate each year?
Adaptive Biotechnologies Corporation (:ADPT) has a recorded net income of $170.28 M. Adaptive Biotechnologies Corporation has generated $-1.56 earnings per share over the last four quarters.
-
What is Adaptive Biotechnologies Corporation's price-to-earnings ratio?
Adaptive Biotechnologies Corporation (:ADPT) has a price-to-earnings ratio of -3.54 and price/earnings-to-growth ratio is -0.4.
